Sanitary napkins segment accounts for largest share of feminine hygiene products
A latest survey has claimed that sanitary napkins segment accounted for largest share of feminine hygiene products in 2019.
According to the new market research...
Control your diabetics with these easily available high vitamanized foods
Many think the art of keeping diabetes under control is a herculean task. This is all the more so during winter, when the craving...
Youth and men not ready to follow Covid-19 measures, claims new study
A new research has claimed that youngsters, men and people with conservative political views are not very ready to comply with Covid-19 measures such...
Multiple health benefits of Moringa leaves
Moringa is a magic among trees. Everything in it comes with some medicinal property, from seeds to leaves to fruits to roots to sap...
How to handle yellowing of plant leaves
Growing plants indoor is a good and healthy habit. But it comes with its own challenges. As indoor plants don't get everything like their...
Dry Eye related latest research reveals rare truths, treatment methods
A latest study conducted in the United Kingdom suggests women of menopausal or post-menopausal age, contact lens users and regular screen users are unaware...
Cipla ups fight against Covid, launches ‘Covi-G’ for rapid antibody detection
Cipla Limited has inked a licensing agreement with a Belgium-based Multi G for the distribution of the latter's Covid-19 Rapid Antibody test kit.
As per...
Biological E gets into war against Covid-19, commences clinical trial of its vaccine candidate
Hyderabad-based pharmaceuticals & Biologics company Biological E. Limited (BE), has said it has initiated a Phase I/II clinical trial of its COVID-19 subunit vaccine...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
RECOMMENDED VIDEOS
